Training of Cameroonian Scientists in Research on Malaria
对喀麦隆科学家进行疟疾研究培训
基本信息
- 批准号:8710368
- 负责人:
- 金额:$ 19.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AfricanAntimalarialsAreaBiologyBiotechnologyCameroonCentral AfricaChildClinical Trials DesignCommunicable DiseasesCountryDiagnostic testsDiseaseDoctor of PhilosophyDrug KineticsDrug resistanceEducational workshopEvolutionFacultyFetal DevelopmentFlow CytometryGoalsGrantHealth ResourcesHealthcareImmunologyInfantInfectionInsecticidesMalariaMaternal and Child HealthMeasuresMentorsMonitorNewborn InfantParasitesPharmaceutical PreparationsPhysiciansPlacentaPlasmodium falciparumPostdoctoral FellowPregnant WomenPrevalencePublic HealthResearchResearch TrainingResidenciesScientistStudentsTimeTrainingTraining ActivityTraining ProgramsUltrasonographyUnited States National Institutes of HealthUniversitiesdesignhigh riskimprovedmemberprogramsskillsvector
项目摘要
ABSTRACT
Malaria, caused by Plasmodium falciparum, is one of the three major infectious diseases in the
world today. The introduction of control measures including insecticide-treated bednets, rapid
diagnostic tests, and intermittent preventative treatment (IPT) have reduced the prevalence of
malaria in a number of African countries, yet malaria remains highly endemic in central Africa
where public health resources are poor. At highest risk of severe infections are pregnant women
and young children. More than ever, well-trained African scientists are needed to monitor the
changing landscape as the malaria picture rapidly changes. Scientists in Cameroon are actively
engage in research on malaria, but additional expertise and faculty are needed to identify malaria-
related problems as they arise and design strategies to solve them. Therefore, the purpose of this
application is to help young Cameroonian scientists acquired the skills necessary for conducting
research on malaria, with a focus on malaria in pregnant women and infants. In 1994, scientists
at the University of Yaound¿ 1, Cameroon, and Georgetown University began collaborating on
malaria at the Biotechnology Center (BTC). Through continuous NIH grant support and a training
grant from the Maternal and Child Health Research Training Program (MCHRT), a group of 5 full-
time faculty members, >6 well-trained technicians, and ~40 students are conducting research at
the BTC. Previous trainees wish to return after completing their post-doctoral and residency
programs in the USA. This application proposes ways to help the malaria group at the BTC
acquire the critical mass and expertise it needs to develop a long-term sustainable research
program on malaria. The specific goal of the application is to provide expertises that is currently
lacking at the BTC that would supplement on-going research. Areas of training include 1) use of
anti-malarial drugs (pharmacokinetics, evolution of parasite-drug resistance, and clinical trial
design), 2) immunology of the placenta, with emphasis on flow cytometry, 3) co-infections
between malaria and other diseases, 4) use of ultrasound for monitoring fetal development, and 5)
vector biology. The program includes training of 3 PhD-level and 4 MS-level students, mentoring
of returning clinicians(s) in OB/GYN and infectious diseases, and training of local physicians in
ultrasound. Three in-country workshops designed and conducted by former FIC trainees are
proposed. These training activities will significantly contribute to the long-term goal of creating a
group of scientists at the BTC whose research will continue to improve the health care of pregnant
women and their newborns.
摘要
疟疾是由恶性疟原虫引起的三大传染病之一。
当今世界。引入控制措施,包括杀虫剂处理的蚊帐,快速
诊断性测试和间歇性预防性治疗(IPT)降低了
疟疾在一些非洲国家蔓延,但疟疾在中部非洲仍然高度流行
公共卫生资源贫乏的地方。严重感染风险最高的是孕妇
和年幼的孩子。比以往任何时候都更需要训练有素的非洲科学家来监测
随着疟疾形势的迅速变化,地貌也在不断变化。喀麦隆的科学家正在积极地
从事疟疾研究,但需要更多的专业知识和教师来识别疟疾-
出现相关问题并设计解决策略。因此,这样做的目的是
申请是为了帮助喀麦隆的年轻科学家获得必要的技能
关于疟疾的研究,重点是孕妇和婴儿的疟疾。1994年,科学家们
在雅温得大学,喀麦隆和乔治敦大学开始合作
生物技术中心(BTC)的疟疾研究。通过NIH持续的赠款支持和培训
来自母婴健康研究培训计划(MCHRT)的赠款,一个由5个完整的-
时代周刊教职员工、6名训练有素的技术人员和约40名学生正在进行研究
比特币。之前的实习生希望在完成博士后和住院医师培训后回国
在美国的项目。这个应用程序提出了帮助BTC疟疾小组的方法
获得开发长期可持续研究所需的临界质量和专业知识
关于疟疾的项目。该应用程序的具体目标是提供当前
BTC缺乏这一点来补充正在进行的研究。培训领域包括1)使用
抗疟疾药物(药代动力学、寄生虫耐药性的演变和临床试验
设计),2)胎盘免疫学,重点是流式细胞术,3)合并感染
疟疾和其他疾病之间的关系,4)使用超声波监测胎儿发育,5)
媒介生物学。该计划包括培训3名博士生和4名MS级学生,辅导
对妇产科和传染病的归国临床医生(S)进行培训,并对当地医生进行
超音波。由前FIC学员设计和举办的三个国内讲习班是
建议。这些培训活动将极大地促进创建一个
BTC的一组科学家,他们的研究将继续改善孕妇的医疗保健
妇女和她们的新生儿。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Diane Wallace Taylor其他文献
Diane Wallace Taylor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Diane Wallace Taylor', 18)}}的其他基金
Immunity to Placental Malaria: Persistence of Antibodies to VAR2CSA
对胎盘疟疾的免疫力:VAR2CSA 抗体的持久性
- 批准号:
8989517 - 财政年份:2014
- 资助金额:
$ 19.4万 - 项目类别:
Immunity to Placental Malaria: Persistence of Antibodies to VAR2CSA
对胎盘疟疾的免疫力:VAR2CSA 抗体的持久性
- 批准号:
8823392 - 财政年份:2014
- 资助金额:
$ 19.4万 - 项目类别:
Training of Cameroonian Scientists in Research on Malaria
对喀麦隆科学家进行疟疾研究培训
- 批准号:
8182903 - 财政年份:2011
- 资助金额:
$ 19.4万 - 项目类别:
Training of Cameroonian Scientists in Research on Malaria
对喀麦隆科学家进行疟疾研究培训
- 批准号:
8496611 - 财政年份:2011
- 资助金额:
$ 19.4万 - 项目类别:
Training of Cameroonian Scientists in Research on Malaria
对喀麦隆科学家进行疟疾研究培训
- 批准号:
8305507 - 财政年份:2011
- 资助金额:
$ 19.4万 - 项目类别:
相似海外基金
Developing inhibitors of Plasmodium Acetyl CoA Synthetase as new multistage antimalarials
开发疟原虫乙酰辅酶A合成酶抑制剂作为新型多级抗疟药
- 批准号:
MR/X030202/1 - 财政年份:2023
- 资助金额:
$ 19.4万 - 项目类别:
Research Grant
Novel Dual-Stage Antimalarials: Machine learning prediction, validation and evolution
新型双阶段抗疟药:机器学习预测、验证和进化
- 批准号:
10742205 - 财政年份:2023
- 资助金额:
$ 19.4万 - 项目类别:
Natural Product Inspired Novel Antimalarials with Radical Cure Potential
受天然产物启发的具有根治潜力的新型抗疟药
- 批准号:
10635649 - 财政年份:2023
- 资助金额:
$ 19.4万 - 项目类别:
Novel Synergistic Antimalarials with Resistance Reversal Function
具有耐药逆转功能的新型协同抗疟药
- 批准号:
10534667 - 财政年份:2022
- 资助金额:
$ 19.4万 - 项目类别:
Plasmodium Protein Kinase Focused Antimalarials Discovery
疟原虫蛋白激酶聚焦抗疟药的发现
- 批准号:
10533634 - 财政年份:2022
- 资助金额:
$ 19.4万 - 项目类别:
DMPK Optimisation of B-hydroxyethylamine Antimalarials
B-羟乙胺抗疟药的 DMPK 优化
- 批准号:
2749037 - 财政年份:2022
- 资助金额:
$ 19.4万 - 项目类别:
Studentship
Development of new lead antimalarials targeting parasite coenzyme A biosynthesis and utilisation.
开发针对寄生虫辅酶 A 生物合成和利用的新型先导抗疟药。
- 批准号:
468862 - 财政年份:2022
- 资助金额:
$ 19.4万 - 项目类别:
Operating Grants
Repurposing antimalarials for the treatment of NTM infections
重新利用抗疟药治疗 NTM 感染
- 批准号:
10646331 - 财政年份:2022
- 资助金额:
$ 19.4万 - 项目类别:
Novel Synergistic Antimalarials with Resistance Reversal Function
具有耐药逆转功能的新型协同抗疟药
- 批准号:
10368441 - 财政年份:2022
- 资助金额:
$ 19.4万 - 项目类别:
Repurposing antimalarials for the treatment of NTM infections
重新利用抗疟药治疗 NTM 感染
- 批准号:
10494711 - 财政年份:2022
- 资助金额:
$ 19.4万 - 项目类别: